Neuroscience News and Research

RSS

Reversing effects of early stage age-related macular degeneration may be possible

A new technique reported in the February 2015 issue of The FASEB Journal suggests that during early stages, it might be possible to reverse age-related macular degeneration, a leading cause of blindness that is currently irreversible. The treatment involving a nanosecond laser may also have further implications for other eye diseases such as diabetic macular oedema, diabetic retinopathy and retinopathy of prematurity.

3 Feb 2015

Vanderbilt researchers discover new reset button for the brain's master biological clock

The discovery of a new reset button for the brain's master biological clock could eventually lead to new treatments for conditions like seasonal affective disorder, reduce the adverse health effects of working the night shift and possibly even cure jet lag.

3 Feb 2015

Findings may lay foundation for treatment of neurodegenerative diseases

This story starts in 1955, upon the death of Albert Einstein, when the pathologist charged with performing the famous scientist's autopsy stole his brain.

3 Feb 2015

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

3 Feb 2015

Musical training in younger years can protect the brain in later life

Scientists have found some of the strongest evidence yet that musical training in younger years can prevent the decay in speech listening skills in later life.

3 Feb 2015

TOS announces FDA approval of new prescription drug for treating binge eating disorder

The United States Food and Drug Administration recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically indicated for BED.

3 Feb 2015

Scientists identify how 'mini-brain' in spinal cord helps keep our body balanced

Walking across an icy parking lot in winter--and remaining upright--takes intense concentration. But a new discovery suggests that much of the balancing act that our bodies perform when faced with such a task happens unconsciously, thanks to a cluster of neurons in our spinal cord that function as a "mini-brain" to integrate sensory information and make the necessary adjustments to our muscles so that we don't slip and fall.

2 Feb 2015

People's perceptions of cost of drug may affect how much they benefit from it

People's perceptions of the cost of a drug may affect how much they benefit from the drug, even when they are receiving only a placebo, according to a new study of people with Parkinson's disease published in the January 28, 2015 online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Feb 2015

Study reveals how the brain can use fatty acids to control liver lipid production

Ways of keeping the heart healthy has widened, with the discovery that the brain can help fight off hardening of the arteries.

31 Jan 2015

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered gene interactions that determine whether cells live or die in such conditions as age-related macular degeneration and ischemic stroke.

31 Jan 2015

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.

30 Jan 2015

Atypical features common in bipolar disorder subtypes, associated with therapy

Atypical features are prevalent in all subtypes of bipolar disorder, a Chinese survey published in Neuroscience Bulletin, shows, and are associated with the use of antidepressant medication in patients with mixed stage and remission subtypes.

30 Jan 2015

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.

30 Jan 2015

Neuroscientists propose new strategy for brain evolution

Little animations trying to master a computer game are teaching neuroscience researchers how the brain evolves when faced with difficult tasks.

30 Jan 2015

Gradual smoking cessation may be key for quitting

Smoking is harmful in almost every respect. Cancer, stroke, and other cardiovascular diseases are just a small part of a well-documented portfolio of serious consequences of smoking.

29 Jan 2015

New eye-tracking device measures severity of concussion and brain injury

New research out of NYU Langone Medical Center could move the medical community one step closer toward effectively detecting concussion and quantifying its severity.

29 Jan 2015

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy.

28 Jan 2015

Reducing A2A adenosine receptor levels prevents memory impairments in Alzheimer's mouse model

A study by scientists from the Gladstone Institutes shows that decreasing the number of A2A adenosine receptors in a particular type of brain cells called astrocytes improved memory in healthy mice. What's more, reducing receptor levels also prevented memory impairments in a mouse model of Alzheimer's disease.

28 Jan 2015

Improving prefrontal cortex activity could help autistic people regulate emotions

Tantrums, irritability, self-injury, depression, anxiety. These symptoms are associated with autism, but they're not considered core symptoms of the disorder. Researchers from the UNC School of Medicine are challenging this assertion. They have used functional MRI to show that - when it comes to the ability to regulate emotions - brain activity in autistic people is significantly different than brain activity in people without autism.

28 Jan 2015

Sanford-Burnham researchers use human pluripotent stem cells to grow new hair

In a new study from Sanford-Burnham Medical Research Institute, researchers have used human pluripotent stem cells to generate new hair. The study represents the first step toward the development of a cell-based treatment for people with hair loss. In the United States alone, more than 40 million men and 21 million women are affected by hair loss.

28 Jan 2015

Neuroscience News and Research

Reversing effects of early stage age-related macular degeneration may be possible

Vanderbilt researchers discover new reset button for the brain's master biological clock

Findings may lay foundation for treatment of neurodegenerative diseases

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Musical training in younger years can protect the brain in later life

TOS announces FDA approval of new prescription drug for treating binge eating disorder

Scientists identify how 'mini-brain' in spinal cord helps keep our body balanced

People's perceptions of cost of drug may affect how much they benefit from it

Study reveals how the brain can use fatty acids to control liver lipid production

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Atypical features common in bipolar disorder subtypes, associated with therapy

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Neuroscientists propose new strategy for brain evolution

Gradual smoking cessation may be key for quitting

New eye-tracking device measures severity of concussion and brain injury

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Reducing A2A adenosine receptor levels prevents memory impairments in Alzheimer's mouse model

Improving prefrontal cortex activity could help autistic people regulate emotions

Sanford-Burnham researchers use human pluripotent stem cells to grow new hair

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News